Bicara Therapeutics Inc.
BCAX
$14.81
$0.271.86%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 489.71M | 520.76M | 203.86M | 203.86M | 230.44M |
| Total Receivables | -- | -- | -- | -- | 100.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 12.82M | 756.00K | 2.22M | 2.22M | 533.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 502.53M | 521.51M | 206.08M | 206.08M | 231.07M |
|
|
|||||
| Total Current Assets | 502.53M | 521.51M | 206.08M | 206.08M | 231.07M |
| Net Property, Plant & Equipment | 845.00K | 544.00K | 619.00K | 619.00K | 815.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.62M | 2.12M | 2.09M | 2.09M | 2.09M |
| Total Assets | 510.00M | 524.17M | 208.78M | 208.78M | 233.98M |
|
|
|||||
| Total Accounts Payable | 4.51M | 1.96M | 4.68M | 4.68M | 3.19M |
| Total Accrued Expenses | 12.88M | 12.21M | 11.08M | 11.08M | 11.61M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 607.00K | 308.00K | 300.00K | 300.00K | 285.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 17.99M | 14.48M | 16.07M | 16.07M | 15.09M |
|
|
|||||
| Total Current Liabilities | 17.99M | 14.48M | 16.07M | 16.07M | 15.09M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 131.00K | 137.00K | 217.00K | 217.00K | 372.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 17.00K |
| Total Liabilities | 18.12M | 14.62M | 16.28M | 16.28M | 15.47M |
|
|
|||||
| Common Stock & APIC | 712.89M | 709.61M | 7.80M | 7.80M | 4.25M |
| Retained Earnings | -221.02M | -200.06M | -182.58M | -182.58M | -153.02M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 491.88M | 509.56M | -174.78M | -174.78M | -148.77M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | 367.28M | 367.28M | 367.28M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | 367.28M | 367.28M | 367.28M |
|
|
|||||
| Total Common Equity | 491.88M | 509.56M | -174.78M | -174.78M | -148.77M |
| Total Preferred Equity | -- | -- | 367.28M | 367.28M | 367.28M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 491.88M | 509.56M | 192.50M | 192.50M | 218.51M |
|
|
|||||